AI assistant
Sending…
Cabaletta Bio, Inc. — Director's Dealing 2019
Oct 25, 2019
33628_dirs_2019-10-24_8680acea-8313-4ebd-8a34-413b46e80d1c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2019-10-24
Reporting Person: DANIELS BRIAN (Director)
More from Cabaletta Bio, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Mar 23